Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3406]
News [7759]
Articles [63]
Editorials [9]
Conferences [207]
elearning [49]
DASISION study on cardiovascular safety in patients with CML-CP
Prof Giuseppe Saglio - University of Turin, Italy
DASISION study on cardiovascular safety in patients with CML-CP ( Prof Giuseppe Saglio - University of Turin, Italy )
18 Feb 2011
The role of epigenetics in cancer treatment
Prof Stephen Baylin - Johns Hopkins University, Maryland, USA
The role of epigenetics in cancer treatment ( Prof Stephen Baylin - Johns Hopkins University, Maryland, USA )
18 Feb 2011
Progress in the treatment of CML
Dr Jerald Radich - Fred Hutchinson Cancer Research Center, Seattle, USA
Progress in the treatment of CML ( Dr Jerald Radich - Fred Hutchinson Cancer Research Center, Seattle, USA )
18 Feb 2011
Advances in the treatment of CLL
Prof Kanti Rai - Long Island Jewish Medical Center, New York, USA
Advances in the treatment of CLL ( Prof Kanti Rai - Long Island Jewish Medical Center, New York, USA )
18 Feb 2011
The role of plasma cell biology in multiple myeloma
Dr William Matsui - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA
The role of plasma cell biology in multiple myeloma ( Dr William Matsui - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )
18 Feb 2011
Key multiple myeloma research from ASH 2010
Prof Pieter Sonneveld - Erasmus University Rotterdam, Netherlands
Key multiple myeloma research from ASH 2010 ( Prof Pieter Sonneveld - Erasmus University Rotterdam, Netherlands )
18 Feb 2011
CLL related research from ASH 2010
Dr Michael Keating- MD Anderson Cancer Center, Texas, USA
CLL related research from ASH 2010 ( Dr Michael Keating- MD Anderson Cancer Center, Texas, USA )
18 Feb 2011
The DASISION chronic myeloid leukaemia trial
Dr Neil Shah - University of California, San Francisco, USA
The DASISION chronic myeloid leukaemia trial ( Dr Neil Shah - University of California, San Francisco, USA )
18 Feb 2011
Key lymphoma research from ASH 2010
Prof Wyndham Wilson - National Cancer Institute, Maryland, USA
Key lymphoma research from ASH 2010 ( Prof Wyndham Wilson - National Cancer Institute, Maryland, USA )
18 Feb 2011
ENESTnd trial comparing nilotinib and imatinib as first line CML therapy
Prof Timothy Hughes - Institute of Medical and Veterinary Science, Adelaide...
ENESTnd trial comparing nilotinib and imatinib as first line CML therapy ( Prof Timothy Hughes - Institute of Medical and Veterinary Science, Adelaide, Australia )
18 Feb 2011
Signalling pathways as a target for cancer therapies
Prof Mariann Bienz - MRC Laboratory of Molecular Biology, Cambridge, UK
Signalling pathways as a target for cancer therapies ( Prof Mariann Bienz - MRC Laboratory of Molecular Biology, Cambridge, UK )
14 Feb 2011
Inotuzumab ozogamicin therapy for indolent B-cell non-Hodgkin's lymphoma
Prof Andre Goy - Hackensack University Medical Center, New Jersey, USA
Inotuzumab ozogamicin therapy for indolent B-cell non-Hodgkin's lymphoma ( Prof Andre Goy - Hackensack University Medical Center, New Jersey, USA )
13 Feb 2011

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation